FDA — authorised 20 August 1952
- Application: NDA008453
- Marketing authorisation holder: SANDOZ
- Local brand name: ANECTINE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Succinylcholine on 20 August 1952 · 2,321 US adverse-event reports
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
Yes. FDA authorised it on 20 August 1952; FDA authorised it on 4 June 2018; FDA authorised it on 15 January 2020.
SANDOZ holds the US marketing authorisation.